NCT05286138View on ClinicalTrials.gov

STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITALY

RecruitingOBSERVATIONAL

Enrollment

10,000

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2052

Conditions

Malignacy, Hemoglobinopathie

Trial Locations (1)

09121

RECRUITING

Azienda Ospedaliera Universitaria Di Cagliari, Cagliari

All Listed Sponsors

lead

Società Italiana Talassemie ed Emoglobinopatie

OTHER